Published on February 13, 2025, 08:00 PM UTC
Hims & Hers (HIMS) stock plunged 26% on Tuesday despite a better-than-expected Q4 report, as investors worry about potential revenue loss from discontinued compounded weight-loss drugs. CFO Yemi Okupe downplayed these concerns, highlighting the company's diversified revenue stream and strong outlook for 2024, but Wall Street remains cautious amid industry-wide changes in semaglutide availability.
Published on: February 25, 2025, 05:01 PM UTC
Major homebuilders face challenges in the spring season due to a potential trade war and high mortgage rates. DR Horton reports a decline in orders, Toll Brothers lowers guidance. Rising land prices, competition, and tariff concerns add to industry uncertainties.
Published on: February 22, 2025, 01:00 PM UTC
Trump's 25% steel tariffs threaten to further inflate construction costs and raise rents for apartments and condos, especially high-rise buildings. Developers may delay projects or seek exemptions as the US faces a housing shortage.
Published on: February 22, 2025, 10:00 AM UTC
Coinbase's case with the SEC was dismissed, boosting shares by 3%. Coinbase claimed the win on social media, but the SEC has not confirmed the decision.
Published on: February 21, 2025, 03:01 PM UTC
Standard Chartered CEO Bill Winters slams EU bonus cap, saying it made bankers lazy and less likely to work hard. The cap, which limited bonuses to two times salary, has been scrapped by the UK. Winters will benefit from the bonus cap overhaul, with a maximum pay packet of £13.1m.
Published on: February 21, 2025, 12:00 PM UTC